Fennec Pharmaceuticals (FENC) FCF Margin (2020 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly FCF Margin came in at 43.28% in Q4 2025, down 2468.0% YoY from 1.83% in Q4 2024, and down 461.21% on a QoQ basis from 11.98% in Q3 2025.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) FCF Margin (2020 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 4 years of FCF Margin data on file, last reported at 43.28% in Q4 2025.
- Quarterly FCF Margin fell 2468.0% year-over-year to 43.28% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 27.94% (down 8103.0% YoY) and the FY2025 annual result came in at 34.19%, down 9095.0% from the prior year.
- FCF Margin eased to 43.28% in Q4 2025, from 11.98% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 147.01% in Q1 2024 to a low of 332.56% in Q1 2023.
- A 3-year average of 56.75% and a median of 42.82% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin jumped 47957 bps — and 2025, when it tumbled 19635 bps.
- Tracing FENC's FCF Margin over 3 years: stood at 49.92% in 2023, then soared by 63 bps to 18.6% in 2024, then sank by 133 bps to 43.28% in 2025.
- The last three FCF Margin figures came in at 43.28% (Q4 2025), 11.98% (Q3 2025), and 38.19% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -43.28% |
| Sep 30, 2025 | 11.98% |
| Jun 30, 2025 | -38.19% |
| Mar 31, 2025 | -49.34% |
| Dec 31, 2024 | -18.60% |
| Sep 30, 2024 | -31.63% |
| Jun 30, 2024 | -115.49% |
| Mar 31, 2024 | 147.01% |
| Dec 31, 2023 | -49.92% |
| Sep 30, 2023 | -42.36% |
| Jun 30, 2023 | -118.68% |
| Mar 31, 2023 | -332.56% |
| Dec 31, 2020 | -1,642.00% |